Published in BMJ on July 07, 2001
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ (2011) 29.14
CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ (2010) 28.70
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ (2010) 22.34
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (2009) 22.18
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med (2009) 21.74
CONSORT statement: extension to cluster randomised trials. BMJ (2004) 16.50
The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol (2003) 16.17
A call for transparent reporting to optimize the predictive value of preclinical research. Nature (2012) 14.63
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ (2007) 14.52
Systematic review of whether nurse practitioners working in primary care can provide equivalent care to doctors. BMJ (2002) 10.90
The effectiveness of mobile-health technology-based health behaviour change or disease management interventions for health care consumers: a systematic review. PLoS Med (2013) 9.74
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med (2010) 9.30
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ (2013) 9.01
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med (2007) 8.46
Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Med Res Methodol (2008) 7.42
Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis. BMJ (2001) 7.13
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Med (2010) 6.88
Systematic reviews of evaluations of prognostic variables. BMJ (2001) 6.69
Can animal models of disease reliably inform human studies? PLoS Med (2010) 6.27
CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration. PLoS Med (2008) 5.85
A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc (2009) 5.81
Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ (2010) 5.68
Assessment of methodological quality of primary studies by systematic reviews: results of the metaquality cross sectional study. BMJ (2005) 5.65
The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed. BMJ (2010) 5.58
Publication bias in reports of animal stroke studies leads to major overstatement of efficacy. PLoS Biol (2010) 5.58
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Bull World Health Organ (2007) 5.38
The effectiveness of mobile-health technologies to improve health care service delivery processes: a systematic review and meta-analysis. PLoS Med (2013) 5.02
Interventions to improve water quality for preventing diarrhoea: systematic review and meta-analysis. BMJ (2007) 4.79
Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis. Circulation (2012) 4.56
Risk of bias versus quality assessment of randomised controlled trials: cross sectional study. BMJ (2009) 4.48
Obstetric outcomes after treatment of periodontal disease during pregnancy: systematic review and meta-analysis. BMJ (2010) 4.44
Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review. BMJ (2006) 4.42
Efficacy of pneumococcal vaccination in adults: a meta-analysis. CMAJ (2009) 4.38
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Trials (2010) 4.28
Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ (2008) 4.12
Blinded independent central review of progression-free survival in phase III clinical trials: important design element or unnecessary expense? J Clin Oncol (2008) 4.11
Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophr Bull (2007) 3.52
Applying systematic review methods to studies of people's views: an example from public health research. J Epidemiol Community Health (2004) 3.48
Evidence of bias and variation in diagnostic accuracy studies. CMAJ (2006) 3.34
Strength of association between umbilical cord pH and perinatal and long term outcomes: systematic review and meta-analysis. BMJ (2010) 3.32
Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review. BMJ (2004) 3.29
Expediting systematic reviews: methods and implications of rapid reviews. Implement Sci (2010) 3.25
Recommendations by Cochrane Review Groups for assessment of the risk of bias in studies. BMC Med Res Methodol (2008) 3.11
Treatment success in cancer: new cancer treatment successes identified in phase 3 randomized controlled trials conducted by the National Cancer Institute-sponsored cooperative oncology groups, 1955 to 2006. Arch Intern Med (2008) 3.07
Effects of acupuncture on rates of pregnancy and live birth among women undergoing in vitro fertilisation: systematic review and meta-analysis. BMJ (2008) 3.05
Standards of reporting of randomized controlled trials in general surgery: can we do better? Ann Surg (2006) 3.01
Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study. BMJ (2010) 2.88
Insecticide-treated nets for the prevention of malaria in pregnancy: a systematic review of randomised controlled trials. PLoS Med (2007) 2.80
Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study. BMJ (2005) 2.80
Bias modelling in evidence synthesis. J R Stat Soc Ser A Stat Soc (2009) 2.74
Diagnostic value of C reactive protein in infections of the lower respiratory tract: systematic review. BMJ (2005) 2.66
Statistics Notes: Validating scales and indexes. BMJ (2002) 2.59
Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis. BMJ (2004) 2.39
Inpatient rehabilitation specifically designed for geriatric patients: systematic review and meta-analysis of randomised controlled trials. BMJ (2010) 2.38
The effects of excluding patients from the analysis in randomised controlled trials: meta-epidemiological study. BMJ (2009) 2.29
Systematic review of prognostic models in traumatic brain injury. BMC Med Inform Decis Mak (2006) 2.29
Comparative efficacy of seven psychotherapeutic interventions for patients with depression: a network meta-analysis. PLoS Med (2013) 2.25
Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials. BMC Cancer (2010) 2.25
CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. J Pharmacol Pharmacother (2010) 2.13
Effects of calcium supplementation on bone density in healthy children: meta-analysis of randomised controlled trials. BMJ (2006) 2.11
No role for quality scores in systematic reviews of diagnostic accuracy studies. BMC Med Res Methodol (2005) 2.11
Family intervention for schizophrenia. Cochrane Database Syst Rev (2010) 2.11
Outcomes in ambulatory chronic systolic and diastolic heart failure: a propensity score analysis. Am Heart J (2006) 2.10
Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis. BMJ (2008) 2.09
Fundoplication versus medical management of gastroesophageal reflux disease: systematic review and meta-analysis. Surg Endosc (2013) 2.07
Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: a prospective multi-centre individual patient data analysis. PLoS One (2009) 2.05
Adequacy and reporting of allocation concealment: review of recent trials published in four general medical journals. BMJ (2005) 2.00
Aminoglycoside extended interval dosing in neonates is safe and effective: a meta-analysis. Arch Dis Child Fetal Neonatal Ed (2005) 1.98
Funding source, trial outcome and reporting quality: are they related? Results of a pilot study. BMC Health Serv Res (2002) 1.93
A comparison of fluoroquinolones versus other antibiotics for treating enteric fever: meta-analysis. BMJ (2009) 1.91
Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis. Int J Cancer (2009) 1.90
Preventing the second episode: a systematic review and meta-analysis of psychosocial and pharmacological trials in first-episode psychosis. Schizophr Bull (2009) 1.85
Systematic review of patellar resurfacing in total knee arthroplasty. Int Orthop (2010) 1.84
Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis. Malar J (2009) 1.80
Types of study in medical research: part 3 of a series on evaluation of scientific publications. Dtsch Arztebl Int (2009) 1.80
Adult Bone Marrow Cell Therapy for Ischemic Heart Disease: Evidence and Insights From Randomized Controlled Trials. Circ Res (2015) 1.80
Reporting methods of blinding in randomized trials assessing nonpharmacological treatments. PLoS Med (2007) 1.77
Factors predisposing women to chronic pelvic pain: systematic review. BMJ (2006) 1.77
Imputation methods for missing outcome data in meta-analysis of clinical trials. Clin Trials (2008) 1.76
Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev (2015) 1.76
A systematic review and meta-analysis of the association between depression and insulin resistance. Diabetes Care (2013) 1.75
Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy. BMJ (2013) 1.74
Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses. CMAJ (2009) 1.73
Alternative approaches to endoscopic ablation for benign enlargement of the prostate: systematic review of randomised controlled trials. BMJ (2008) 1.70
A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol (2010) 1.70
Effectiveness of disease-management programs for improving diabetes care: a meta-analysis. CMAJ (2010) 1.66
Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials. BMJ (2004) 1.64
Association between framing of the research question using the PICOT format and reporting quality of randomized controlled trials. BMC Med Res Methodol (2010) 1.63
The scandal of poor epidemiological research. BMJ (2004) 1.60
Integrating disease control strategies: balancing water sanitation and hygiene interventions to reduce diarrheal disease burden. Am J Public Health (2007) 1.56
Are treatments more effective than placebos? A systematic review and meta-analysis. PLoS One (2013) 1.56
Yoga for prenatal depression: a systematic review and meta-analysis. BMC Psychiatry (2015) 1.54
Effects of 5-hydroxytryptamine (serotonin) type 3 antagonists on symptom relief and constipation in nonconstipated irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials. Clin Gastroenterol Hepatol (2008) 1.52
Uses and misuses of the STROBE statement: bibliographic study. BMJ Open (2011) 1.50
Substitution of physicians by nurses in primary care: a systematic review and meta-analysis. BMC Health Serv Res (2014) 1.48
Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA (1995) 45.41
Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet (1998) 19.31
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA (2001) 19.20
The hazards of scoring the quality of clinical trials for meta-analysis. JAMA (1999) 17.00
What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ (1999) 13.99
Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. Control Clin Trials (1995) 9.85
Controversy in counting and attributing events in clinical trials. N Engl J Med (1979) 7.25
Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis. BMJ (2001) 7.13
Value of flow diagrams in reports of randomized controlled trials. JAMA (2001) 7.06
A method for assessing the quality of a randomized control trial. Control Clin Trials (1981) 6.63
Subverting randomization in controlled trials. JAMA (1995) 6.10
Statistics notes. Treatment allocation in controlled trials: why randomise? BMJ (1999) 5.86
Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. N Engl J Med (1980) 5.23
Incorporating variations in the quality of individual randomized trials into meta-analysis. J Clin Epidemiol (1992) 4.86
Impact of study quality on outcome in placebo-controlled trials of homeopathy. J Clin Epidemiol (1999) 4.74
Randomisation. BMJ (1991) 4.66
Randomised trials, human nature, and reporting guidelines. Lancet (1996) 4.51
Assessing the quality of reports of randomised trials: implications for the conduct of meta-analyses. Health Technol Assess (1999) 4.45
Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. INDANA Group. Lancet (1999) 3.81
Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials. JAMA (2001) 3.32
A quality assessment of randomized control trials of primary treatment of breast cancer. J Clin Oncol (1986) 3.14
The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial. Neurology (1994) 2.95
Factors relevant to the validity of experiments in social settings. Psychol Bull (1957) 2.91
Meta-analysis: statistical alchemy for the 21st century. J Clin Epidemiol (1995) 2.83
Methodologic guidelines for systematic reviews of randomized control trials in health care from the Potsdam Consultation on Meta-Analysis. J Clin Epidemiol (1995) 2.73
Controversies in meta-analysis: the case of the trials of serum cholesterol reduction. Stat Methods Med Res (1993) 2.22
Putting trials on trial--the costs and consequences of small trials in depression: a systematic review of methodology. J Epidemiol Community Health (1997) 1.83
The randomized clinical trial: bias in analysis. Circulation (1981) 1.64
Amniotomy or oxytocin for induction of labor. Re-analysis of a randomized controlled trial. Acta Obstet Gynecol Scand (1988) 1.33
Statistical methods for assessing agreement between two methods of clinical measurement. Lancet (1986) 211.50
Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA (1995) 45.41
The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med (2001) 37.70
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet (2001) 31.74
Measuring agreement in method comparison studies. Stat Methods Med Res (1999) 31.11
Multiple significance tests: the Bonferroni method. BMJ (1995) 23.46
Confidence intervals rather than P values: estimation rather than hypothesis testing. Br Med J (Clin Res Ed) (1986) 18.51
The hazards of scoring the quality of clinical trials for meta-analysis. JAMA (1999) 17.00
Analysis of serial measurements in medical research. BMJ (1990) 16.69
Cronbach's alpha. BMJ (1997) 13.79
Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol (2001) 12.72
Misleading meta-analysis. BMJ (1995) 11.94
The scandal of poor medical research. BMJ (1994) 11.58
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med (2001) 11.48
Statistical guidelines for contributors to medical journals. Br Med J (Clin Res Ed) (1983) 10.90
Statistics notes. Logarithms. BMJ (1996) 10.56
Statistics in medical journals. Stat Med (1983) 9.80
Evaluating non-randomised intervention studies. Health Technol Assess (2003) 9.69
Comparing methods of measurement: why plotting difference against standard method is misleading. Lancet (1995) 9.14
Statistics notes: Analysing controlled trials with baseline and follow up measurements. BMJ (2001) 8.98
Statistics and ethics in medical research: III How large a sample? Br Med J (1980) 8.78
Better reporting of randomised controlled trials: the CONSORT statement. BMJ (1996) 8.39
More informative abstracts revisited. Ann Intern Med (1990) 8.26
Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol (2000) 7.95
Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis. BMJ (2001) 7.13
Transforming data. BMJ (1996) 6.78
Regression towards the mean. BMJ (1994) 6.57
Measurement error. BMJ (1996) 6.18
Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals. JAMA (1994) 5.80
Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair. Transfusion (1999) 5.67
Statistics notes. The odds ratio. BMJ (2000) 5.61
Who benefits from medical interventions? BMJ (1994) 5.58
The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials. BMC Med Res Methodol (2001) 5.43
Applying the right statistics: analyses of measurement studies. Ultrasound Obstet Gynecol (2003) 5.40
How can medical journals help prevent poor medical research? Some opportunities presented by electronic publishing. Lancet (1999) 5.27
Statistics notes. Interaction 2: Compare effect sizes not P values. BMJ (1996) 5.18
Correlation, regression, and repeated data. BMJ (1994) 4.88
Calculating correlation coefficients with repeated observations: Part 1--Correlation within subjects. BMJ (1995) 4.87
REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer (2005) 4.85
Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study. Lancet (1999) 4.83
Social factors and height of primary schoolchildren in England and Scotland. J Epidemiol Community Health (1978) 4.73
Randomisation. BMJ (1991) 4.66
Patients' preferences and randomised trials. Lancet (1996) 4.64
Early enteral feeding versus "nil by mouth" after gastrointestinal surgery: systematic review and meta-analysis of controlled trials. BMJ (2001) 4.47
Measurement error and correlation coefficients. BMJ (1996) 4.38
Indirect comparisons of competing interventions. Health Technol Assess (2005) 4.33
Socioeconomic differentials in wealth and health. BMJ (1993) 4.32
Statistical aspects of prognostic factor studies in oncology. Br J Cancer (1994) 4.22
Measurement error. BMJ (1996) 4.13
Survival analysis part I: basic concepts and first analyses. Br J Cancer (2003) 4.08
Some examples of regression towards the mean. BMJ (1994) 4.01
Survival probabilities (the Kaplan-Meier method). BMJ (1998) 3.98
Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials. Int J Epidemiol (2007) 3.84
A catalogue of reporting guidelines for health research. Eur J Clin Invest (2010) 3.83
Magnesium and myocardial infarction. Lancet (1994) 3.74
Effects of a drug overdose in a television drama on presentations to hospital for self poisoning: time series and questionnaire study. BMJ (1999) 3.52
Grey literature in meta-analyses of randomized trials of health care interventions. Cochrane Database Syst Rev (2007) 3.51
Frequency and reasons for outcome reporting bias in clinical trials: interviews with trialists. BMJ (2011) 3.50
HIV and male circumcision--a systematic review with assessment of the quality of studies. Lancet Infect Dis (2005) 3.49
The benefits and harms of breast cancer screening: an independent review. Br J Cancer (2013) 3.43
Transformations, means, and confidence intervals. BMJ (1996) 3.42
Reporting on quality of life in randomised controlled trials: bibliographic study. BMJ (1998) 3.37
Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons. BMJ (1995) 3.35
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study. JAMA (1999) 3.34
Measurement error proportional to the mean. BMJ (1996) 3.34
Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives. Health Technol Assess (2001) 3.32
National study of health and growth: standards of attained height, weight and triceps skinfold in English children 5 to 11 years old. Ann Hum Biol (1977) 3.23
The use of transformation when comparing two means. BMJ (1996) 3.22
Smoking and health promotion in Nazi Germany. J Epidemiol Community Health (1994) 3.20
A note on the use of the intraclass correlation coefficient in the evaluation of agreement between two methods of measurement. Comput Biol Med (1990) 3.18
Interaction 3: How to examine heterogeneity. BMJ (1996) 3.17
Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelines. Br J Cancer (2004) 3.15
Survival analysis part II: multivariate data analysis--an introduction to concepts and methods. Br J Cancer (2003) 3.06
Calculating correlation coefficients with repeated observations: Part 2--Correlation between subjects. BMJ (1995) 2.94
Randomised trial of educational visits to enhance use of systematic reviews in 25 obstetric units. BMJ (1998) 2.94
Outcome selection bias in meta-analysis. Stat Methods Med Res (2005) 2.86
Statistics and ethics in medical research. VI--Presentation of results. Br Med J (1980) 2.85
Do all men attending departments of genitourinary medicine need to be screened for non-gonococcal urethritis? Int J STD AIDS (2002) 2.81
The effects of combining education and enforcement to reduce tobacco sales to minors. A study of four northern California communities. JAMA (1991) 2.77
A prognostic model for ovarian cancer. Br J Cancer (2001) 2.77
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. J Am Podiatr Med Assoc (2001) 2.71
Survival analysis Part III: multivariate data analysis -- choosing a model and assessing its adequacy and fit. Br J Cancer (2003) 2.71
Baseline comparisons in randomized clinical trials. Stat Med (1991) 2.69
Predictors of physician's smoking cessation advice. JAMA (1991) 2.66
More informative abstracts. Ann Intern Med (1987) 2.63
Funding clinical research. Lancet (1999) 2.63
Effect of arterial revascularisation on survival: a systematic review of studies comparing bilateral and single internal mammary arteries. Lancet (2001) 2.61
One and two sided tests of significance. BMJ (1994) 2.61
The causes and effects of socio-demographic exclusions from clinical trials. Health Technol Assess (2005) 2.38
The Swiss HIV Cohort Study: rationale, organization and selected baseline characteristics. Soz Praventivmed (1994) 2.38
Genital Chlamydia trachomatis infections in Uppsala County, Sweden, 1985-1993: declining rates for how much longer? Sex Transm Dis (1995) 2.36
Monitoring of large randomised clinical trials: a new approach with Bayesian methods. Lancet (2001) 2.35
Commentary: understanding it all--health, meta-theories, and mortality trends. BMJ (1997) 2.35
Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev (2003) 2.32
c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes. Br J Cancer (1991) 2.29
Are randomised controlled trials in the BMJ different? BMJ (2001) 2.26
Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study. Clin Infect Dis (2001) 2.24